Skip to Content

129 Results Found

  • Article
  • Open Access
657 Views
29 Pages

Development of Replicon Cell Pools Bearing a Flavivirus RNA Replicon as a Source of HIV-1 Gag-Pol for Lentiviral Vector Production

  • Aitolkyn Kydyrbayeva,
  • Viktoriya Keyer,
  • Tolganay Kulatay,
  • Gulzat Zauatbayeva and ,
  • Bakytkali Ingirbay,
  • Maral Zhumabekova,
  • Arman Abeev,
  • Gaziza Nigmatulla and
  • Alexandr V. Shustov
  • + 4 authors+ 0 author

28 May 2026

Lentiviral vectors (LVs) are indispensable tools in cell and gene therapy. Rising demand has created a global shortage of LVs, driving the development of novel packaging approaches. We report a novel vector packaging approach using autonomously repli...

(This article belongs to the Section Biotechnology)
  • Review
  • Open Access
31 Citations
17,426 Views
20 Pages

Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles

  • Kenneth C. McCullough,
  • Panagiota Milona,
  • Lisa Thomann-Harwood,
  • Thomas Démoulins and ,
  • Pavlos Englezou,
  • Rolf Suter and
  • Nicolas Ruggli
  • + 2 authors+ 0 author

16 October 2014

Dendritic cells (DC) play essential roles determining efficacy of vaccine delivery with respect to immune defence development and regulation. This renders DCs important targets for vaccine delivery, particularly RNA vaccines. While delivery of interf...

(This article belongs to the Special Issue Vaccine Vector)
  • Review
  • Open Access
32 Citations
22,893 Views
22 Pages

29 January 2010

RNA replicons are derived from either positive- or negative-strand RNA viruses. They represent disabled virus vectors that are not only avirulent, but also unable to revert to virulence. Due to autonomous RNA replication, RNA replicons are able to dr...

(This article belongs to the Special Issue Influenza: Pandemics and Vaccinations)
  • Review
  • Open Access
78 Citations
17,369 Views
23 Pages

7 November 2016

Single-stranded RNA viruses of both positive and negative polarity have been used as vectors for vaccine development. In this context, alphaviruses, flaviviruses, measles virus and rhabdoviruses have been engineered for expression of surface protein...

(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)
  • Article
  • Open Access
148 Views
19 Pages

Orthoflavivirus-Based, DNA-Launched, Self-Amplifying and Self-Packing RNA Replicons for Vaccine Development

  • Morgan E. Freney,
  • Julian D. J. Sng,
  • Alberto A. Amarilla,
  • Kexin Yan and ,
  • Andrew Young,
  • Yin Xiang Setoh,
  • Valentina A. Volchkova,
  • Paul R. Young,
  • Viktor E. Volchkov and
  • Alexander A. Khromykh
  • + 6 authors+ 1 author

10 November 2026

Self-amplifying vaccines based on alphavirus replicons are well established. Preclinical studies of self-amplifying vaccines based on orthoflaviviruses have also been described and include replicons based on Kunjin virus (KUNV). KUNV is an Australian...

(This article belongs to the Section Immunology)
  • Review
  • Open Access
32 Citations
8,475 Views
22 Pages

Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses

  • Rafaela S. Fernandes,
  • Marjorie C. L. C. Freire,
  • Renata V. Bueno,
  • Andre S. Godoy and ,
  • Laura H. V. G. Gil and
  • Glaucius Oliva
  • + 1 author+ 0 author

30 May 2020

Single-stranded positive RNA ((+) ssRNA) viruses include several important human pathogens. Some members are responsible for large outbreaks, such as Zika virus, West Nile virus, SARS-CoV, and SARS-CoV-2, while others are endemic, causing an enormous...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
12 Citations
4,425 Views
17 Pages

Establishment of an Antiplasmodial Vaccine Based on PfRH5-Encoding RNA Replicons Stabilized by Cationic Liposomes

  • Wesley L. Fotoran,
  • Jamile Ramos da Silva,
  • Christiane Glitz,
  • Luís Carlos de Souza Ferreira and
  • Gerhard Wunderlich

Background: Nucleic acid-based vaccines have been studied for the past four decades, but the approval of the first messenger RNA (mRNA) vaccines during the COVID-19 pandemic opened renewed perspectives for the development of similar vaccines against...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
3 Citations
3,939 Views
15 Pages

5 May 2022

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, SARS2) remains a great global health threat and demands identification of more effective and SARS2-targeted antiviral drugs, even with successful development of anti-SARS2 vaccines. Vir...

(This article belongs to the Topic Infectious Diseases)
  • Review
  • Open Access
9 Citations
5,018 Views
12 Pages

DNA-based gene therapy and vaccine development has received plenty of attention lately. DNA replicons based on self-replicating RNA viruses such as alphaviruses and flaviviruses have been of particular interest due to the amplification of RNA transcr...

(This article belongs to the Special Issue Plasmid DNA for Gene Therapy and DNA Vaccine Applications)
  • Communication
  • Open Access
8 Citations
3,663 Views
15 Pages

Sofosbuvir Suppresses the Genome Replication of DENV1 in Human Hepatic Huh7 Cells

  • Madoka Kurosawa,
  • Fumihiro Kato,
  • Takayuki Hishiki,
  • Saori Ito and ,
  • Hiroki Fujisawa,
  • Tatsuo Yamaguchi,
  • Misato Moriguchi,
  • Kohei Hosokawa,
  • Tadashi Watanabe and
  • Masahiro Fujimuro
  • + 7 authors+ 2 authors

7 February 2024

Dengue virus (DENV) causes dengue fever and dengue hemorrhagic fever, and DENV infection kills 20,000 people annually worldwide. Therefore, the development of anti-DENV drugs is urgently needed. Sofosbuvir (SOF) is an effective drug for HCV-related d...

(This article belongs to the Special Issue The Interaction Between Cell and Virus, 2nd Edition)
  • Review
  • Open Access
92 Citations
13,100 Views
29 Pages

Single-stranded RNA viruses such as alphaviruses, flaviviruses, measles viruses and rhabdoviruses are characterized by their capacity of highly efficient self-amplification of RNA in host cells, which make them attractive vehicles for vaccine develop...

(This article belongs to the Special Issue Oncolytic Virotherapy)
  • Article
  • Open Access
3 Citations
1,699 Views
15 Pages

Development of a Noninfectious Japanese Encephalitis Virus Replicon for Antiviral Drug Screening and Gene Function Studies

  • Yang Yang,
  • Jiayang Zheng,
  • Yafang Lin,
  • Yan Zhang and ,
  • Qianming Zhao,
  • Hailong Zhang,
  • Junjie Zhang,
  • Zongjie Li,
  • Ke Liu and
  • Jianchao Wei
  • + 9 authors+ 4 authors

27 May 2025

Viral replicons are efficient tools to understand the mechanisms of viral replication and screen antiviral drugs. In this study, a viral-cDNA-based replicon of Japanese encephalitis virus (JEV), which is the causative agent of Japanese encephalitis,...

(This article belongs to the Section Animal Viruses)
  • Review
  • Open Access
21 Citations
6,162 Views
10 Pages

Alphaviruses have been engineered as vectors for high-level transgene expression. Originally, alphavirus-based vectors were applied as recombinant replication-deficient particles, subjected to expression studies in mammalian and non-mammalian cell li...

(This article belongs to the Special Issue Advances in DNA Vaccines)
  • Review
  • Open Access
18 Citations
4,663 Views
23 Pages

RNA Combined with Nanoformulation to Advance Therapeutic Technologies

  • Eduarda Santos Lima,
  • Déborah dos Santos,
  • Atena Liriel Souza,
  • Maria Eduarda Macedo and ,
  • Mariana Evangelista Bandeira,
  • Sérgio Santos Silva Junior,
  • Bianca Sampaio Dotto Fiuza,
  • Vinicius Pinto Costa Rocha,
  • Larissa Moraes dos Santos Fonseca and
  • Bruna Aparecida Souza Machado
  • + 7 authors+ 2 authors

21 November 2023

Nucleic acid-based therapies have the potential to address numerous diseases that pose significant challenges to more traditional methods. RNA-based therapies have emerged as a promising avenue, utilizing nanoformulation treatments to target a range...

(This article belongs to the Section Biopharmaceuticals)
  • Article
  • Open Access
38 Citations
6,449 Views
29 Pages

Structural Analysis and Whole Genome Mapping of a New Type of Plant Virus Subviral RNA: Umbravirus-Like Associated RNAs

  • Jingyuan Liu,
  • Elizabeth Carino,
  • Sayanta Bera,
  • Feng Gao and ,
  • Jared P. May and
  • Anne E. Simon
  • + 1 author+ 0 author

9 April 2021

We report the biological and structural characterization of umbravirus-like associated RNAs (ulaRNAs), a new category of coat-protein dependent subviral RNA replicons that infect plants. These RNAs encode an RNA-dependent RNA polymerase (RdRp) follow...

(This article belongs to the Section General Virology)
  • Article
  • Open Access
20 Citations
5,786 Views
15 Pages

A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses

  • Christin Schmidt,
  • Florian D. Hastert,
  • Julia Gerbeth,
  • Tim Beissert and ,
  • Ugur Sahin,
  • Mario Perkovic and
  • Barbara S. Schnierle
  • + 2 authors+ 0 author

23 August 2022

Alphaviruses such as the human pathogenic chikungunya virus (CHIKV) and Ross River virus (RRV) can cause explosive outbreaks raising public health concerns. However, no vaccine or specific antiviral treatment is yet available. We recently established...

(This article belongs to the Section Nucleic Acid (DNA and mRNA) Vaccines)
  • Review
  • Open Access
8 Citations
4,265 Views
14 Pages

12 November 2024

Alphaviruses are known for being model viruses for studying cellular functions related to viral infections but also for causing epidemics in different parts of the world. More recently, alphavirus-based expression systems have demonstrated efficacy a...

(This article belongs to the Section General Virology)
  • Article
  • Open Access
1 Citations
1,969 Views
14 Pages

Minimal Polymerase-Containing Precursor Required for Chikungunya Virus RNA Synthesis

  • David Aponte-Diaz,
  • Abha Jain,
  • Jayden M. Harris,
  • Jamie J. Arnold and
  • Craig E. Cameron

28 November 2025

Alphaviruses pose a growing global health threat, with Chikungunya virus (CHIKV) epidemics ongoing. Although several CHIKV vaccine candidates have progressed to late-stage clinical evaluation, none have yet achieved licensure or widespread availabili...

(This article belongs to the Special Issue 15-Year Anniversary of Viruses)
  • Article
  • Open Access
35 Citations
6,682 Views
16 Pages

Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication

  • Ulrik Fahnøe,
  • Long V. Pham,
  • Carlota Fernandez-Antunez,
  • Rui Costa and ,
  • Lizandro René Rivera-Rangel,
  • Andrea Galli,
  • Shan Feng,
  • Lotte S. Mikkelsen,
  • Judith M. Gottwein and
  • Jens Bukh
  • + 7 authors+ 2 authors

18 January 2022

The COVID-19 pandemic continues to threaten healthcare systems worldwide due to the limited access to vaccines, suboptimal treatment options, and the continuous emergence of new and more transmissible SARS-CoV-2 variants. Reverse-genetics studies of...

(This article belongs to the Section SARS-CoV-2 and COVID-19)
  • Review
  • Open Access
10 Citations
3,881 Views
13 Pages

13 September 2022

Alphaviruses have been engineered as expression vectors for vaccine development and gene therapy. Due to the feature of RNA self-replication, alphaviruses can provide exceptional direct cytoplasmic expression of transgenes based on the delivery of re...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer III)
  • Article
  • Open Access
3,060 Views
13 Pages

A Novel SARS-CoV-2-Derived Infectious Vector System

  • Ghada Elfayres,
  • Yong Xiao,
  • Qinghua Pan,
  • Chen Liang and ,
  • Benoit Barbeau and
  • Lionel Berthoux
  • + 1 author+ 0 author

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19. The development of antiviral drugs for COVID-19 has been hampered by the requirement of a biosafety level 3 (BSL3) laboratory for experiments related to...

  • Article
  • Open Access
10 Citations
4,717 Views
18 Pages

Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B

  • Carolina Chiale,
  • Timur O. Yarovinsky,
  • Stephen W. Mason,
  • Bhaskara R. Madina and ,
  • Manisha Menon,
  • Marie M. Krady,
  • Safiehkhatoon Moshkani,
  • Anasuya Chattopadhyay Pal,
  • Bijan Almassian and
  • Valerian Nakaar
  • + 7 authors+ 2 authors

Virus-like vesicles (VLV) are hybrid vectors based on an evolved Semliki Forest virus (SFV) RNA replicon and the envelope glycoprotein (G) from vesicular stomatitis virus (VSV). Previously, we showed that VLV can be used to express protein antigens a...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Article
  • Open Access
1,704 Views
20 Pages

Development of a New Feline Combination Vaccine Including a Novel RNA Particle Vaccine Against Feline Leukemia Virus

  • Willem Huisman,
  • Aart Mommen,
  • Stephanie Basten,
  • Kim Driessen and ,
  • Peter Pepels,
  • Qi Cao,
  • Hans Holtslag,
  • Melissa Ann Bourgeois and
  • Jacqueline Pearce
  • + 4 authors+ 0 author

16 July 2026

Background/Objectives: We describe the rationale, design and evaluation of a novel feline combination vaccine (Nobivac® NXT HCPChFeLV) incorporating RNA particle technology against feline leukemia virus (FeLV) alongside live attenuated components...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
45 Citations
7,042 Views
13 Pages

Highly Efficient Genome Editing Using Geminivirus-Based CRISPR/Cas9 System in Cotton Plant

  • Bo Li,
  • Chunyang Fu,
  • Jiawei Zhou,
  • Fengjiao Hui and ,
  • Qiongqiong Wang,
  • Fuqiu Wang,
  • Guanying Wang,
  • Zhongping Xu,
  • Lianlian Che and
  • Shuangxia Jin
  • + 8 authors+ 3 authors

16 September 2022

Upland cotton (Gossypium hirsutum), an allotetraploid, contains At- and Dt- subgenome and most genes have multiple homologous copies, which pose a huge challenge to investigate genes’ function due to the functional redundancy. Therefore, it is...

(This article belongs to the Special Issue Plant Genome Editing: State-of-the-Art and Perspectives in China)
  • Article
  • Open Access
8 Citations
5,145 Views
21 Pages

Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line

  • Hossein M. Elbadawy,
  • Mohi I. Mohammed Abdul,
  • Naif Aljuhani,
  • Adriana Vitiello and ,
  • Francesco Ciccarese,
  • Mohamed A. Shaker,
  • Heba M. Eltahir,
  • Giorgio Palù,
  • Veronica Di Antonio and
  • Gualtiero Alvisi
  • + 16 authors+ 11 authors

18 September 2020

Despite the introduction of directly acting antivirals (DAAs), for the treatment of hepatitis C virus (HCV) infection, their cost, patient compliance, and viral resistance are still important issues to be considered. Here, we describe the generation...

(This article belongs to the Special Issue RNA Interference (RNAi) for Antiviral Therapy)
  • Review
  • Open Access
15 Citations
4,744 Views
13 Pages

9 December 2022

Self-replicating RNA viruses have become attractive delivery vehicles for therapeutic applications. They are easy to handle, can be rapidly produced in large quantities, and can be delivered as recombinant viral particles, naked or nanoparticle-encap...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
48 Citations
7,697 Views
14 Pages

23 August 2020

RNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro-RNA (miRNA) have demonstrated efficacy in gene silencing for therapeutic...

(This article belongs to the Special Issue RNA Interference (RNAi) for Antiviral Therapy)
  • Review
  • Open Access
27 Citations
11,438 Views
17 Pages

Trans-Amplifying RNA: A Journey from Alphavirus Research to Future Vaccines

  • Ayşegül Yıldız,
  • Cristian Răileanu and
  • Tim Beissert

25 March 2024

Replicating RNA, including self-amplifying RNA (saRNA) and trans-amplifying RNA (taRNA), holds great potential for advancing the next generation of RNA-based vaccines. Unlike in vitro transcribed mRNA found in most current RNA vaccines, saRNA or taRN...

(This article belongs to the Section General Virology)
  • Review
  • Open Access
267 Citations
65,420 Views
26 Pages

An Update on Self-Amplifying mRNA Vaccine Development

  • Anna K. Blakney,
  • Shell Ip and
  • Andrew J. Geall

28 January 2021

This review will explore the four major pillars required for design and development of an saRNA vaccine: Antigen design, vector design, non-viral delivery systems, and manufacturing (both saRNA and lipid nanoparticles (LNP)). We report on the major i...

(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)
  • Review
  • Open Access
14 Citations
7,451 Views
29 Pages

The Interplay Between Therapeutic Self-Amplifying RNA and the Innate Immune System: Balancing Efficiency and Reactogenicity

  • Dmitry Kunyk,
  • Marina Plotnikova,
  • Mikhail Bespalov,
  • Daniil Shevyrev and ,
  • Sergey Klotchenko,
  • Roman Ivanov and
  • Vasiliy Reshetnikov
  • + 2 authors+ 0 author

15 September 2025

Self-amplifying RNA (saRNA) is a promising platform for the production of vaccines, anti-tumor therapeutics, and gene therapy solutions. One of the advantages of the saRNA platform is the ability to use small doses of the therapeutic while maintainin...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
39 Citations
15,822 Views
22 Pages

Reverse Genetic Approaches for the Generation of Recombinant Zika Virus

  • Ginés Ávila-Pérez,
  • Aitor Nogales,
  • Verónica Martín,
  • Fernando Almazán and
  • Luis Martínez-Sobrido

31 October 2018

Zika virus (ZIKV) is an emergent mosquito-borne member of the Flaviviridae family that was responsible for a recent epidemic in the Americas. ZIKV has been associated with severe clinical complications, including neurological disorder such as Guillai...

(This article belongs to the Special Issue New Advances on Zika Virus Research)
  • Article
  • Open Access
4 Citations
2,553 Views
27 Pages

A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening

  • Maximilian Erdmann,
  • Peter A. C. Wing,
  • Isobel Webb,
  • Maia Kavanagh Williamson and ,
  • Tuksin Jearanaiwitayakul,
  • Edward Sullivan,
  • James Bazire,
  • Iart Luca Shytaj,
  • Jane A. McKeating and
  • Andrew D. Davidson
  • + 6 authors+ 1 author

23 April 2025

SARS-CoV-2 is classified as a containment level 3 (CL3) pathogen, limiting research access and antiviral testing. To address this, we developed a non-infectious viral surrogate system using reverse genetics to generate sub-genomic replicons. These re...

(This article belongs to the Special Issue Coronaviruses Pathogenesis, Immunity, and Antivirals (2nd Edition))
  • Article
  • Open Access
5 Citations
4,240 Views
16 Pages

18 August 2023

Zika virus (ZIKV) is a type of RNA virus that belongs to the Flaviviridae family. We have reported the construction of a DNA-launched replicon of the Asian-lineage Natal RGN strain and the production of single-round infectious particles (SRIPs) via t...

(This article belongs to the Special Issue Advances in Alphavirus and Flavivirus Research)
  • Article
  • Open Access
1,611 Views
29 Pages

Virion-Independent Extracellular Vesicle (EV)-Dependent Transmission of SARS-CoV-2 as a Potential New Mechanism of Viral RNA Spread in Human Cells

  • Nergiz Ekmen,
  • Ali Riza Koksal,
  • Dong Lin,
  • Di Tian and ,
  • Paul Thevenot,
  • Sarah Glover and
  • Srikanta Dash
  • + 2 authors+ 0 author

22 January 2026

The concentration of extracellular vesicles (EVs) in the peripheral blood of COVID-19 patients is increased. Nevertheless, their potential role in the transmission of infection remains unclear. This study was performed to determine whether EVs produc...

(This article belongs to the Section Coronaviruses)
  • Article
  • Open Access
10 Citations
5,822 Views
15 Pages

Construction of a Chikungunya Virus, Replicon, and Helper Plasmids for Transfection of Mammalian Cells

  • Mayra Colunga-Saucedo,
  • Edson I. Rubio-Hernandez,
  • Miguel A. Coronado-Ipiña,
  • Sergio Rosales-Mendoza and ,
  • Claudia G. Castillo and
  • Mauricio Comas-Garcia
  • + 1 author+ 0 author

31 December 2022

The genome of Alphaviruses can be modified to produce self-replicating RNAs and virus-like particles, which are useful virological tools. In this work, we generated three plasmids for the transfection of mammalian cells: an infectious clone of Chikun...

(This article belongs to the Special Issue Physical Virology - Viruses at Multiple Levels of Complexity)
  • Article
  • Open Access
1 Citations
3,467 Views
20 Pages

Exogenous Rubella Virus Capsid Proteins Enhance Virus Genome Replication

  • Min-Hsin Chen,
  • Cara C. Burns,
  • Emily Abernathy,
  • Adaeze A. Ogee-Nwankwo and
  • Joseph P. Icenogle

Enhanced replication of rubella virus (RuV) and replicons by de novo synthesized viral structural proteins has been previously described. Such enhancement can occur by viral capsid proteins (CP) alone in trans. It is not clear whether the CP in the v...

(This article belongs to the Section Viral Pathogens)
  • Article
  • Open Access
2 Citations
3,611 Views
27 Pages

West Nile Virus Subgenomic RNAs Modulate Gene Expression in a Neuronal Cell Line

  • Maria Bampali,
  • Adamantia Kouvela,
  • Nikolaos Kesesidis,
  • Katerina Kassela and ,
  • Nikolas Dovrolis and
  • Ioannis Karakasiliotis
  • + 1 author+ 0 author

20 May 2024

Subgenomic flaviviral RNAs (sfRNAs) are small non-coding products of the incomplete degradation of viral genomic RNA. They accumulate during flaviviral infection and have been associated with many functional roles inside the host cell. Studies so far...

(This article belongs to the Section Invertebrate Viruses)
  • Article
  • Open Access
15 Citations
5,332 Views
20 Pages

Parsimonious Scenario for the Emergence of Viroid-Like Replicons De Novo

  • Pablo Catalán,
  • Santiago F. Elena,
  • José A. Cuesta and
  • Susanna Manrubia

9 May 2019

Viroids are small, non-coding, circular RNA molecules that infect plants. Different hypotheses for their evolutionary origin have been put forward, such as an early emergence in a precellular RNA World or several de novo independent evolutionary orig...

(This article belongs to the Special Issue Viroid-2018: International Conference on Viroids and Viroid-Like RNAs)
  • Article
  • Open Access
7 Citations
5,961 Views
25 Pages

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses

  • Nadia Oreshkova,
  • Sebenzile K. Myeni,
  • Niraj Mishra,
  • Irina C. Albulescu and ,
  • Tim J. Dalebout,
  • Eric J. Snijder,
  • Peter J. Bredenbeek,
  • Kai Dallmeier and
  • Marjolein Kikkert
  • + 4 authors+ 0 author

16 December 2021

The tremendous global impact of the current SARS-CoV-2 pandemic, as well as other current and recent outbreaks of (re)emerging viruses, emphasize the need for fast-track development of effective vaccines. Yellow fever virus 17D (YF17D) is a live-atte...

  • Article
  • Open Access
6 Citations
2,736 Views
18 Pages

Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity

  • Fan Wang,
  • Ruyi Chen,
  • Jiayi Zhong,
  • Anqi Zhou and ,
  • Ran Peng,
  • Bao Xue,
  • Yuan Zhou,
  • Jielin Tang,
  • Xinwen Chen and
  • Qi Yang
  • + 5 authors+ 0 author

15 May 2025

Nipah virus (NiV), a highly lethal zoonotic pathogen causing encephalitis and respiratory diseases with mortality rates up to 40–70%, faces research limitations due to its strict biosafety level 4 (BSL-4) containment requirements, hindering ant...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
18 Citations
5,979 Views
17 Pages

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

  • Mouraya Hussein,
  • Zaria Andrade dos Ramos,
  • Monique A. Vink,
  • Pascal Kroon and ,
  • Zhenghao Yu,
  • Luis Enjuanes,
  • Sonia Zuñiga,
  • Ben Berkhout and
  • Elena Herrera-Carrillo
  • + 4 authors+ 0 author

6 March 2023

The current SARS-CoV-2 pandemic forms a major global health burden. Although protective vaccines are available, concerns remain as new virus variants continue to appear. CRISPR-based gene-editing approaches offer an attractive therapeutic strategy as...

(This article belongs to the Special Issue Advances in Antiviral Agents against SARS-CoV-2 and Its Variants)
  • Article
  • Open Access
11 Citations
4,682 Views
12 Pages

The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication

  • Lucca R. Policastro,
  • Isabela Dolci,
  • Andre S. Godoy,
  • José V. J. Silva Júnior and ,
  • Uriel E. A. Ruiz,
  • Igor A. Santos,
  • Ana C. G. Jardim,
  • Kirandeep Samby,
  • Jeremy N. Burrows and
  • Rafaela S. Fernandes
  • + 8 authors+ 3 authors

21 June 2022

Chikungunya virus (CHIKV) is the causative agent of chikungunya fever, a disabling disease that can cause long-term severe arthritis. Since the last large CHIKV outbreak in 2015, the reemergence of the virus represents a serious public health concern...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
48 Citations
10,430 Views
27 Pages

18 November 2020

Viral vectors can generate high levels of recombinant protein expression providing the basis for modern vaccine development. A large number of different viral vector expression systems have been utilized for targeting viral surface proteins and tumor...

(This article belongs to the Special Issue The Application of Viruses to Biotechnology)
  • Communication
  • Open Access
12 Citations
4,517 Views
16 Pages

16 December 2021

Crimean–Congo hemorrhagic fever virus (CCHFV) infrequently causes hemorrhagic fever in humans with a case fatality rate of 30%. Currently, there is neither an internationally approved antiviral drug nor a vaccine against the virus. A replicon b...

(This article belongs to the Special Issue Perspective Technologies of Vaccination and Immunotherapy)
  • Article
  • Open Access
41 Citations
6,491 Views
13 Pages

Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus

  • Chaker El Kalamouni,
  • Etienne Frumence,
  • Sandra Bos,
  • Jonathan Turpin and ,
  • Brice Nativel,
  • Wissal Harrabi,
  • David A. Wilkinson,
  • Olivier Meilhac,
  • Gilles Gadea and
  • Wildriss Viranaïcken
  • + 7 authors+ 2 authors

20 December 2018

Heme oxygenase-1 (HO-1), a rate-limiting enzyme involved in the degradation of heme, is induced in response to a wide range of stress conditions. HO-1 exerts antiviral activity against a broad range of viruses, including the Hepatitis C virus, the hu...

(This article belongs to the Special Issue New Advances on Zika Virus Research)
  • Article
  • Open Access
14 Citations
3,870 Views
13 Pages

Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking

  • Reina Sasaki-Tanaka,
  • Kalyan C. Nagulapalli Venkata,
  • Hiroaki Okamoto,
  • Mitsuhiko Moriyama and
  • Tatsuo Kanda

Hepatitis A virus (HAV) infection is a major cause of acute hepatitis worldwide and occasionally causes acute liver failure and can lead to death in the absence of liver transplantation. Although HAV vaccination is available, the prevalence of HAV va...

(This article belongs to the Special Issue Hepatitis Virus Infection and Molecular Research 2022)
  • Article
  • Open Access
1 Citations
3,188 Views
19 Pages

19 November 2024

Background/Objectives: Since its emergence in 2019, the rapid spread of SARS-CoV-2 led to the global pandemic. Recent large-scale dengue fever outbreaks overlapped with the COVID-19 pandemic, leading to increased cases of co-infection and posing seve...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
1 Citations
1,250 Views
27 Pages

Hepatitis C Virus 5′UTR Sequences That Bind eIF3 and Ribosomal 40S Subunits Confer Stimulation of Minus-Strand RNA Synthesis

  • Attiya Qadoos Malik,
  • Lyudmila Shalamova,
  • Mozhdeh Khajouei,
  • Jonas Budnik and ,
  • Anna-Lena Hell,
  • Elena Jost,
  • Gesche K. Gerresheim,
  • Oliver Rossbach and
  • Michael Niepmann
  • + 4 authors+ 0 author

Hepatitis C Virus (HCV) is a plus-strand RNA virus that replicates its genome via a minus-strand intermediate, which in turn is the template for the synthesis of progeny plus-strand genomes. In order to characterize sequence elements in the HCV 5&pri...

(This article belongs to the Special Issue Advanced Molecular Research on the Diagnosis and Treatment of Chronic Liver Diseases)
  • Review
  • Open Access
7 Citations
3,651 Views
12 Pages

Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes

  • Noémie Oechslin,
  • Maliki Ankavay,
  • Darius Moradpour and
  • Jérôme Gouttenoire

28 March 2023

Hepatitis E virus (HEV) has received relatively little attention for decades although it is now considered as one of the most frequent causes of acute hepatitis worldwide. Our knowledge of this enterically-transmitted, positive-strand RNA virus and i...

(This article belongs to the Special Issue State-of-the-Art Virology Research in Switzerland)
  • Article
  • Open Access
49 Citations
7,830 Views
14 Pages

Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines

  • Roshan Goswami,
  • Derek T. O’Hagan,
  • Roberto Adamo and
  • Barbara C. Baudner

Recent approval of mRNA vaccines to combat COVID-19 have highlighted the potential of this platform. Lipid nanoparticles (LNP) is the delivery vehicle of choice for mRNA as they prevent its enzymatic degradation by encapsulation. We have recently sho...

(This article belongs to the Special Issue Liposomes for Vaccine Delivery)

of 3